Press release
-
Press Release
GIBO Announces Strategic Collaboration with E Total Technology Sdn Bhd to Accelerate Deployment of AI Compute Centers Featuring NVIDIA’s Most Advanced Chips
KUALA LUMPUR, Malaysia, Dec. 15, 2025 /PRNewswire/ — GIBO Holdings Ltd. (NASDAQ: GIBO) today announced a strategic collaboration with Malaysia-based…
Read More » -
Press Release
Gloo Unveils the First Benchmark Exposing How AI Misses Christian Worldview and Values
Research-backed framework shows models lack explicit biblical grounding, theological coherence and moral clarity around key dimensions of human flourishing BOULDER,…
Read More » -
Press Release
OsteoCentric Technologies Appoints RJ Brideau to Board of Directors
AUSTIN, Texas, Dec. 15, 2025 /PRNewswire/ — OsteoCentric Technologies announced today the appointment of RJ Brideau to its Board of…
Read More » -
Press Release
Opus Fund Services Tops Global Custodian’s Hedge Fund Administration Awards for Fourth Consecutive Year
Opus wins 2025 Administrator of the Year, Best Client Service and Best Technology awards NEW YORK and LONDON, Dec. 15,…
Read More » -
Press Release
Premier Equipment Company acquires Winston Tractor Company
ROCKY MOUNT, N.C., Dec. 15, 2025 /PRNewswire/ — Premier Equipment Company [premierequipmentsales.com] acquired Winston Tractor Company based in Winston-Salem, NC on…
Read More » -
Press Release
All-new Hyundai NEXO Achieves Maximum Five-Star Rating in Euro NCAP Safety Assessment
Hyundai’s next-generation hydrogen fuel-cell electric SUV earns top scores across all major safety categories Achieves outstanding results in Adult and…
Read More » -
Press Release
Kenai Therapeutics Announces First Patient Dosed in Phase 1 REPLACE™ Clinical Trial of Neuron Replacement Cell Therapy RNDP-001 for Idiopathic Parkinson’s Disease
Fast Track designation granted by U.S. FDA Initial safety, tolerability and brain imaging data from the trial are expected in…
Read More » -
Press Release
Diakonos Oncology to Present Corporate Overview and Participate in Panel at 2026 Biotech Showcase
HOUSTON, Dec. 15, 2025 /PRNewswire/ — Diakonos Oncology Corp., a clinical-stage biotechnology company developing a new generation of immunotherapies to treat…
Read More » -
Press Release
Immusoft Secures FDA Orphan Drug Designation for ISP-002 in MPS II, a Progressive Lysosomal Storage Disease
Orphan Drug Designation for MPS II builds on Immusoft’s clinical progress in MPS I and supports expansion of its engineered…
Read More »